Bath & Body Works Beat Estimates With Someone Else's Money — Now Comes the Real Test

kev_larFounder & Lead Developer
·BBWI forecast →

⚠️ Not financial advice. This post is for informational and educational purposes only. Forecasts and commentary are model outputs and opinions, may be inaccurate, and are not a recommendation to buy or sell any security or asset. Do your own research. AI-assisted: this article was drafted with AI and reviewed by a human before publishing.

Here's a fun party trick: report an earnings beat, watch the headlines write themselves, and hope nobody checks under the hood. That's essentially what Bath & Body Works pulled off back in May, and now the bill comes due on August 26.

Let's rewind. When BBWI reported Q1 2026 on May 26, the tape said EPS of $0.32 against a $0.29 consensus — a tidy 10.8% beat, revenue also nudging past expectations. Cue the "resilient consumer demand" headlines. Except the beat had a co-signer: an $88 million interchange fee litigation settlement, a one-time windfall that had nothing to do with candles, lotions, or foot cream flying off shelves. Strip that out, add back $8 million in transformation costs, and adjusted operating income actually fell roughly 28% year-over-year. That's not a rounding error. That's the difference between "the business is fine" and "the business is under real pressure and got bailed out by a lawyer."

I'll also flag — because good journalism means showing you the messy parts — that TipRanks' data feed appears to have the beat/miss backwards relative to everyone else covering the print. Take that as a reminder that even "consensus" numbers get mangled in transit sometimes. The more corroborated read, across multiple sources, is that BBWI beat on paper while quietly limping underneath.

Why This Matters Right Now

None of this would be more than a footnote if Q2 earnings weren't landing on August 26 — nine days from today. That report doesn't get an $88 million cushion. This is the quarter where we find out if the "underlying operational weakness" was a one-off wobble or the new normal. Q1 sales were already down about 3% year-over-year, and management's response — a "store facelift" under their so-called Consumer First Formula strategy — is a real initiative, but it's also exactly the kind of thing companies announce when same-store sales need a narrative.

The Bull Case Isn't Crazy

To be fair to the optimists: this is still a company throwing off $729 million in trailing free cash flow with $820 million of cash on hand and gross margins sitting at a genuinely impressive 43%+. That's not a business circling the drain — it's a business that knows how to run a store and keep customers coming back for three-wick candles they didn't know they needed. Jefferies bumped its target to $23. The stock has technically broken above the $19.85 resistance level, and the 52-week range ($14.28–$32.32) suggests there's real room to run if sentiment turns. A new board leadership hand in Wendy Arlin adds a fresh-set-of-eyes narrative, and a reported $250 million bond buyback shows some balance sheet housekeeping.

The Bear Case Isn't Going Away

But here's the part the bulls have to explain away: negative stockholders' equity of -$1.13 billion, layered on top of $4.7 billion in debt. That's a capital structure with no margin for error, and it's precisely why the most recent analyst call on record is a lukewarm Hold with a $25 price target — not exactly a conviction buy. Add 8.22% short interest into the mix, and you've got a stock where the skeptics have real money on the table, not just an opinion.

My Take

I don't think this is a "sell everything" situation, but I also don't think you should be fooled twice. The May print taught us that BBWI's headline numbers and its actual operating health are currently two different stories — and the market, for a few weeks, was happy to read only the flattering one. August 26 strips away the litigation crutch. If adjusted operating income keeps sliding without a one-time gain to hide behind, that $23 Jefferies target and the bullish breakout chart start looking like wishful technical drawing rather than fundamentals.

Watch the $18.50 level as the tell — that's roughly where the bull thesis breaks. Above $20.94 with real volume, the accumulate case gets interesting. Everywhere in between is just people guessing what a candle company's balance sheet can survive.

This one reports in nine days. Set a reminder, not a rumor.

More on BBWI


Market commentary from the K3vl4r desk — not personalized investment advice. More posts →